Both AFL (Aflac Incorporated) and GL (Globe Life Inc.) operate in the insurance sector, yet they pursue different customer bases and geographic footprints. This stock comparison is relevant for investors weighing a diversified, dividend-focused supplemental insurer against a domestic life and health carrier with faster premium growth but more recent underwriting volatility. Because the two names diverge on growth drivers, momentum, and risk factors, a side-by-side review of their relative performance and market positioning can help traders and long-term investors clarify which profile better fits current market conditions.
Aflac Incorporated is the largest provider of supplemental insurance, with two reporting segments: Aflac Japan, which generates the majority of revenue, and Aflac U.S. The company sells cancer, accident, dental, vision, disability, and life products primarily through workplace and direct-to-consumer channels. In recent weeks, AFL shares have shown rebuilding momentum after a softer stretch, with a double-digit one-month gain in some recent readings and a positive year-to-date return.
Recent sentiment has been shaped by a few countervailing forces. In its most recent quarterly results, the company posted adjusted earnings per share (EPS) slightly below consensus while revenue beat estimates, helped by favorable investment gains. Pressure in Japan — including reinsurance dynamics, lapses, and a weaker yen — has weighed on earned premiums, although new product sales have been strong. A previously disclosed cybersecurity incident remains a monitored risk. Offsetting these concerns is exceptional capital strength: Aflac's Economic Solvency Ratio (ESR, a measure of capital adequacy) has been reported above 200%, and its U.S. Risk-Based Capital (RBC) ratio comfortably above 600%. Management continues to return capital through buybacks and a growing dividend.
Globe Life Inc. is a U.S.-focused life and supplemental health insurer serving lower- and middle-income families through divisions including American Income Life, Liberty National, Family Heritage, Direct to Consumer, and United American. In recent market activity, GL has delivered a stronger year-to-date and one-year return than AFL, but its near-term trend has been choppier, with the shares pulling back from their 52-week high.
The most recent quarters tell a mixed story. Globe Life posted double-digit year-over-year profit growth early in the year and initially raised guidance, but a subsequent quarterly report prompted a second downward revision to its full-year earnings outlook. The adjustments were driven by an underwriting loss at its Evry Health unit and elevated Medicare Supplement claims tied to processing delays. Life premiums have also decelerated, and producing-agent counts at its flagship channel have declined. On the positive side, health premium growth remains robust, management is expanding buybacks, and an artificial intelligence rollout across underwriting and administration is aimed at lowering expenses and improving agent productivity. The regulatory environment has also cleared, with the SEC concluding its investigation without recommending enforcement action.
Tickeron offers hundreds of AI trading bots that collectively monitor thousands of different tickers, each built around its own trading style, strategy, timeframe, performance record, and set of covered symbols. Because not every automated strategy performs equally well in every market, Tickeron curates a dedicated Trending AI Robots section that highlights the strategies most suited to current conditions. Many of these bots feature detailed statistics, including win rates, trade frequency, and historical performance ranges, giving traders a data-driven way to filter signal quality rather than relying on intuition alone. Exploring this curated list can help investors identify the automated approaches currently gaining traction across the market.
The clearest contrast between the two names is geography and growth profile. AFL derives most of its earnings from Japan, exposing it to currency translation and demographic headwinds, but it benefits from scale, product diversification, and a defensive capital-return profile. GL is purely domestic and faster-growing in health lines such as Medicare Supplement, but that growth has recently come with higher claims severity and margin compression.
On valuation, GL trades at a lower trailing price-to-earnings (P/E) multiple than AFL, a gap that reflects Globe Life's elevated earnings volatility and recent guidance cuts. AFL's premium, by contrast, is supported by its dividend-growth track record and capital resilience. On momentum, GL holds the stronger longer-horizon return, while AFL has shown more consistent short-term stability. Risk factors also differ: AFL's key watch items are Japan persistency and cybersecurity, whereas GL's are health-underwriting profitability and agent recruiting. Sector exposure is comparable, but sentiment currently rewards AFL's steadiness over GL's faster-but-bumpier growth.
Based on observable factors such as trend consistency, stability, catalysts, and relative positioning, Tickeron's AI would currently lean toward AFL over GL. While GL offers stronger longer-term momentum and a cheaper valuation, its consecutive guidance revisions and health-claims strain introduce greater near-term trend uncertainty. AFL's steadier price action, exceptional capital ratios, and 43-year dividend-growth record point to more reliable trend consistency in the current environment. This is a probabilistic assessment of relative strength rather than a definitive forecast, and the balance of these factors could shift as new earnings and market data emerge.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AFL saw its Momentum Indicator move above the 0 level on October 08, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In 47 of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at 62%.
The Moving Average Convergence Divergence (MACD) for AFL just turned positive on October 07, 2026. Looking at past instances where AFL's MACD turned positive, the stock continued to rise in 26 of 46 cases over the following month. The odds of a continued upward trend are 57%.
AFL moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AFL crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +2.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where AFL advanced for three days, in 200 of 366 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
The Aroon Indicator entered an Uptrend today. In 141 of 277 cases where AFL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 51%.
The 10-day RSI Indicator for AFL moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 21 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 52%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 30 of 64 cases where AFL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 47%.
AFL broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 33 (best 1 - 100 worst), indicating outstanding price growth. AFL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.052) is normal, around the industry mean (1.337). P/E Ratio (13.325) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (0.463). Dividend Yield (0.020) settles around the average of (0.047) among similar stocks. AFL's P/S Ratio (3.313) is slightly higher than the industry average of (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
GL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 21 of 33 cases where GL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 64%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GL's RSI Oscillator exited the oversold zone, 7 of 15 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 47%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 35 of 59 cases where GL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on GL as a result. In 65 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for GL just turned positive on November 09, 2026. Looking at past instances where GL's MACD turned positive, the stock continued to rise in 27 of 46 cases over the following month. The odds of a continued upward trend are 59%.
Following a +4.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where GL advanced for three days, in 216 of 377 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 40%.
The Aroon Indicator for GL entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 46 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating fairly steady price growth. GL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.962) is normal, around the industry mean (1.337). P/E Ratio (10.273) is within average values for comparable stocks, (19.773). GL's Projected Growth (PEG Ratio) (1.360) is slightly higher than the industry average of (0.463). Dividend Yield (0.008) settles around the average of (0.047) among similar stocks. P/S Ratio (2.251) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
AFL | GL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 40 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 68 Overvalued | |
PROFIT vs RISK RATING 1..100 | 3 | 46 | |
SMR RATING 1..100 | 94 | 85 | |
PRICE GROWTH RATING 1..100 | 33 | 52 | |
P/E GROWTH RATING 1..100 | 59 | 36 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GL's Valuation (68) in the null industry is in the same range as AFL (77) in the Life Or Health Insurance industry. This means that GL’s stock grew similarly to AFL’s over the last 12 months.
AFL's Profit vs Risk Rating (3) in the Life Or Health Insurance industry is somewhat better than the same rating for GL (46) in the null industry. This means that AFL’s stock grew somewhat faster than GL’s over the last 12 months.
GL's SMR Rating (85) in the null industry is in the same range as AFL (94) in the Life Or Health Insurance industry. This means that GL’s stock grew similarly to AFL’s over the last 12 months.
AFL's Price Growth Rating (33) in the Life Or Health Insurance industry is in the same range as GL (52) in the null industry. This means that AFL’s stock grew similarly to GL’s over the last 12 months.
GL's P/E Growth Rating (36) in the null industry is in the same range as AFL (59) in the Life Or Health Insurance industry. This means that GL’s stock grew similarly to AFL’s over the last 12 months.
| AFL | GL | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 52% | 1 day ago 47% |
| Stochastic ODDS (%) | 1 day ago 47% | 1 day ago 59% |
| Momentum ODDS (%) | 3 days ago 62% | 1 day ago 63% |
| MACD ODDS (%) | 6 days ago 57% | 1 day ago 59% |
| TrendWeek ODDS (%) | 1 day ago 57% | 1 day ago 57% |
| TrendMonth ODDS (%) | 1 day ago 53% | 1 day ago 43% |
| Advances ODDS (%) | 1 day ago 55% | 1 day ago 57% |
| Declines ODDS (%) | N/A | 6 days ago 40% |
| BollingerBands ODDS (%) | 1 day ago 48% | 1 day ago 64% |
| Aroon ODDS (%) | 1 day ago 51% | 1 day ago 35% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AFL’s FA Score shows that 2 FA rating(s) are green while GL’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AFL’s TA Score shows that 6 TA indicator(s) are bullish while GL’s TA Score has 6 bullish TA indicator(s).
AFL (@Life/Health Insurance) experienced а +2.10% price change this week, while GL (@Life/Health Insurance) price change was +3.32% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +2.31%. For the same industry, the average monthly price growth was +3.70%, and the average quarterly price growth was -0.78%.
AFL is expected to report earnings on Feb 03, 2027.
GL is expected to report earnings on Feb 10, 2027.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, AFL has been loosely correlated with CNO. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AFL jumps, then CNO could also see price increases.
A.I.dvisor indicates that over the last year, GL has been loosely correlated with CNO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if GL jumps, then CNO could also see price increases.